The global market for Next Generation Sequencers was estimated at US$16.6 Billion in 2024 and is projected to reach US$43.3 Billion by 2030, growing at a CAGR of 17.3% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Next Generation Sequencers market.
NGS stands out not just for its volume handling but also for its lower sample requirements, higher accuracy, and the ability to detect rare genetic variants. These attributes make it an essential tool in diverse fields such as medicine, agriculture, and environmental science, advancing genomic research, clinical diagnostics, and forensic investigations. The NGS process is intricate, beginning with the construction of a sequencing library where DNA or cDNA samples are fragmented and linked to unique molecular adaptors for easy identification. This is followed by clonal amplification of the DNA fragments on a solid surface to enhance signal detection during sequencing, using technologies that employ a `sequencing by synthesis` approach. Instruments involved in this process detect each nucleotide addition either through optical signals or, as in Ion Torrent technology, electrical signals produced by hydrogen ions released during DNA synthesis. The data analysis phase is complex, involving multiple stages of interpretation to transform raw sequencing data into valuable genetic insights.
The broad application of NGS across various sectors underscores its advantages of high throughput, speed, and cost-efficiency. In clinical research, NGS aids in identifying genetic variations associated with diseases, paving the way for targeted therapies and playing a vital role in reproductive health through genetic anomaly screenings. In agriculture, it accelerates crop improvement by facilitating plant genetic studies, leading to the cultivation of more robust crop varieties. NGS has been particularly crucial during global health emergencies, such as the COVID-19 pandemic, by enabling rapid viral genomic sequencing, which assists in tracking mutations and vaccine development. The future of NGS looks promising with ongoing advancements expected to enhance personalized medicine, agricultural development, and more, fueled by growth drivers such as integration with cloud computing, advancements in bioinformatics, rising consumer interest in personalized medicine, expanding academic and clinical research, evolving regulatory and ethical frameworks, strategic collaborations, and increased investments in emerging markets.
Global Next Generation Sequencers Market - Key Trends and Drivers Summarized
Next-Generation Sequencing (NGS) technologies, initiated in 2005, have revolutionized the field of genetics by allowing for the simultaneous sequencing of multiple DNA strands, a significant advancement over the traditional Sanger sequencing. This technology, originally dubbed 'massively-parallel sequencing,' offers unprecedented speed and reduced costs, making extensive genomic studies more accessible. While Sanger sequencing is still utilized for smaller projects or to validate NGS results due to its high accuracy, NGS excels in efficiency and scalability, analyzing hundreds to thousands of genes across various samples in a single run. NGS detects a wide range of genomic features from single nucleotide variants to complex structural variations and RNA fusions, facilitating extensive genetic analyses that were previously unfeasible.NGS stands out not just for its volume handling but also for its lower sample requirements, higher accuracy, and the ability to detect rare genetic variants. These attributes make it an essential tool in diverse fields such as medicine, agriculture, and environmental science, advancing genomic research, clinical diagnostics, and forensic investigations. The NGS process is intricate, beginning with the construction of a sequencing library where DNA or cDNA samples are fragmented and linked to unique molecular adaptors for easy identification. This is followed by clonal amplification of the DNA fragments on a solid surface to enhance signal detection during sequencing, using technologies that employ a `sequencing by synthesis` approach. Instruments involved in this process detect each nucleotide addition either through optical signals or, as in Ion Torrent technology, electrical signals produced by hydrogen ions released during DNA synthesis. The data analysis phase is complex, involving multiple stages of interpretation to transform raw sequencing data into valuable genetic insights.
The broad application of NGS across various sectors underscores its advantages of high throughput, speed, and cost-efficiency. In clinical research, NGS aids in identifying genetic variations associated with diseases, paving the way for targeted therapies and playing a vital role in reproductive health through genetic anomaly screenings. In agriculture, it accelerates crop improvement by facilitating plant genetic studies, leading to the cultivation of more robust crop varieties. NGS has been particularly crucial during global health emergencies, such as the COVID-19 pandemic, by enabling rapid viral genomic sequencing, which assists in tracking mutations and vaccine development. The future of NGS looks promising with ongoing advancements expected to enhance personalized medicine, agricultural development, and more, fueled by growth drivers such as integration with cloud computing, advancements in bioinformatics, rising consumer interest in personalized medicine, expanding academic and clinical research, evolving regulatory and ethical frameworks, strategic collaborations, and increased investments in emerging markets.
Scope of Study:
The report analyzes the Next Generation Sequencers market in terms of units by the following Segments, and Geographic Regions/Countries:- Segments: Product (Consumables, Platforms, Services); End-Use (Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End-Uses)
- Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Consumables segment, which is expected to reach US$26.6 Billion by 2030 with a CAGR of a 17.1%. The Platforms segment is also set to grow at 16.2% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $4.5 Billion in 2024, and China, forecasted to grow at an impressive 22.8% CAGR to reach $10.0 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Next Generation Sequencers Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Next Generation Sequencers Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Next Generation Sequencers Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Agilent Technologies, Inc., Becton, Dickinson and Company, Fluidigm Corporation, Illumina Inc., Oxford Gene Technology and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 93 companies featured in this Next Generation Sequencers market report include:
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- Fluidigm Corporation
- Illumina Inc.
- Oxford Gene Technology
- Oxford Nanopore Technologies
- Pacific Biosciences of California Inc.
- QIAGEN N.V.
- RainDance Technologies Inc.
- Roche Sequencing
- Thermo Fischer Scientific Inc.
This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:
- Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
- Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
- Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
- Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
- Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
- Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
- Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- Fluidigm Corporation
- Illumina Inc.
- Oxford Gene Technology
- Oxford Nanopore Technologies
- Pacific Biosciences of California Inc.
- QIAGEN N.V.
- RainDance Technologies Inc.
- Roche Sequencing
- Thermo Fischer Scientific Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 299 |
| Published | June 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 16.6 Billion |
| Forecasted Market Value ( USD | $ 43.3 Billion |
| Compound Annual Growth Rate | 17.3% |
| Regions Covered | Global |
